NDC product
Nighttime Severe Cold and Cough
NDC 68163-541 · RARITAN PHARMACEUTICALS INC
Key facts
| Product NDC | 68163-541 |
|---|---|
| Proprietary name | Nighttime Severe Cold and Cough |
| Nonproprietary name | ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE |
| Substances | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE |
| Dosage form | POWDER, FOR SOLUTION |
| Route | ORAL |
| Labeler | RARITAN PHARMACEUTICALS INC |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC] |
| Marketing start | Mar 22, 2019 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: